The 2021 eAA Wrap Up with Dr. Ellie Dommett & Matt Wingfield

Cognitive enhancing drugs are thought to be used by up to 25% of students in universities to boost their concentration and are often regarded as a form of cheating, and yet universities have no effective ways of managing their use. We do know that certain factors increase the likelihood of using these drugs, including stress and competitiveness. As more assessment moves online we will look at some of the ways in which assessment design might increase or decrease drug use.

During this end-of-year wrap up, we'll hear from Dr. Ellie Dommett as she explores connections between cognitive enhancing drugs and the increasing use of online assessment. Joining Dr. Ellie Dommett for this fascinating topic will be eAA CEO, Matt Wingfield, who will follow with a look back at 2021, and announce some exciting eAA events news for 2022.

Dr Ellie Dommett is a Reader in Neuroscience at King’s College London. She conducts research into Attention Deficit Hyperactivity Disorder and its treatment with psychostimulant drugs, which are also used as cognitive-enhancers by people without ADHD. Alongside her neuroscience research, she conducts education research, focusing on digital education.